InvestorsObserver
×
News Home

Can Spruce Biosciences Inc (SPRB) Stock Rise to the Top of Healthcare Sector Monday?

Monday, June 06, 2022 10:37 AM | InvestorsObserver Analysts

Mentioned in this article

Can Spruce Biosciences Inc (SPRB) Stock Rise to the Top of Healthcare Sector Monday?

Spruce Biosciences Inc (SPRB) is around the middle of the Healthcare sector according to InvestorsObserver. SPRB received an overall rating of 29, which means that it scores higher than 29% of stocks. Additionally, Spruce Biosciences Inc scored a 60 in the Healthcare sector, ranking it higher than 60% of stocks in that sector.

Overall Score - 29
SPRB has an Overall Score of 29. Find out what this means to you and get the rest of the rankings on SPRB!

What do These Ratings Mean?

Trying to find the best stocks can be a daunting task. There are a wide variety of ways to analyze stocks in order to determine which ones are performing the strongest. *Investors Observer* makes the entire process easier by using percentile rankings that allows you to easily find the stocks who have the strongest evaluations by analysts. This ranking system incorporates numerous factors used by analysts to compare stocks in greater detail. This allows you to find the best stocks available in the healthcare sector with relative ease. These percentile-ranked scores using both fundamental and technical analysis give investors an easy way to view the attractiveness of specific stocks. Stocks with the highest scores have the best evaluations by analysts working on Wall Street.

What's Happening With Spruce Biosciences Inc Stock Today?

Spruce Biosciences Inc (SPRB) stock has fallen -2.73% while the S&P 500 has risen 1.32% as of 10:29 AM on Monday, Jun 6. SPRB is lower by -$0.04 from the previous closing price of $1.65 on volume of 47,521 shares. Over the past year the S&P 500 is down -1.51% while SPRB is lower by -87.19%. SPRB lost -$1.89 per share the over the last 12 months. Click Here to get the full Stock Report for Spruce Biosciences Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App